CME Outfitters Announces neuroscienceCME TV Broadcast: "Exploring Atypical Antipsychotics as an Augmentation Option for Major Depressive Disorder" Premieres Wed, Dec. 12

CME Outfitters announces an upcoming live and interactive neuroscienceCME TV activity titled "Exploring Atypical Antipsychotics as an Augmentation Option for Major Depressive Disorder." Offered as a simultaneous satellite broadcast, webcast, and telephone audioconference premiering Wednesday, December 12, 2007, from 12:00 p.m.-1:00 p.m. ET, the activity will focus on examining the neurobiology of depression, evaluating the effectiveness of traditional antidepressant medications, and exploring atypical antipsychotics as an augmentation option for patients that do not remit with traditional antidepressant therapies.

Rockville, MD (PRWEB) November 19, 2007 -- CME Outfitters, LLC, an independent accredited provider of multidisciplinary medical education programming and related healthcare communications services, is pleased to announce an upcoming live and interactive evidence-based neuroscienceCME TV activity titled "Exploring Atypical Antipsychotics as an Augmentation Option for Major Depressive Disorder."

Premiering Wednesday, December 12, 2007, from 12:00 p.m.-1:00 p.m. ET, the activity will focus on examining the neurobiology of depression, evaluating the effectiveness of traditional antidepressant medications, and exploring atypical antipsychotics as an augmentation option for patients that do not remit with traditional antidepressant therapies. The recorded satellite broadcast will re-air from 3:00 p.m.-4:00 p.m. ET. This CE activity will also be available as an archived webcast, podcast, and telephone audioconference shortly after the broadcast premiere.

There is no fee to participate or receive CE credit for this activity; however, registration is required. Three forms of registration are accepted:

Online: Visit the activity details page at http://www.neuroscienceCME.com/cmea.asp?ID=270 and click the Register icon.

Phone: Call 877.CME.PROS (877.263.7767).

Fax: Visit the activity details page at http://www.neuroscienceCME.com/cmea.asp?ID=270, print and complete the activity details form, and fax to 240.243.1033.

Statement of Need:

Major depressive disorder is a debilitating affective disorder associated with significant morbidity and mortality. Numerous treatment options with varying mechanisms of action exist, but the biological heterogeneity of this condition often results in differential patient responses. Understanding the neurobiology of depression is critical to identifying optimal treatment strategies for each patient.

Although there are a variety of nonpharmacologic and pharmacologic treatment strategies, data from the NIMH-sponsored Sequenced Treatment Alternatives to Relieve Depression (STAR*D) indicate that only one-third of patients achieve remission with an initial therapy. These findings illustrate the need for safe and effective alternate treatments that improve outcomes in patients with major depressive disorder. Atypical antipsychotics may represent an augmentation option for patients who fail to respond to traditional therapies. In this live, evidence-based neuroscienceCME TV activity, the experts will review the neurobiology of depression and remission rates for current therapies, and explore alternate strategies for the management of depression.

Moderator:

Ned H. Kalin, MD

Hedberg Professor and Chairman

Department of Psychiatry

The University of Wisconsin Medical School

Director, HealthEmotions Research Institute

Madison, WI

Faculty:

Alexander J. Bodkin, MD

Assistant Professor of Psychiatry

Harvard Medical School

Director, Clinical Psychopharmacology Research Program

McLean Hospital

Boston, MA

Mark Hyman Rapaport, MD

Chairman, Department of Psychiatry and Behavioral Neurosciences

Cedars-Sinai Medical Center

Vice Chairman and Professor in Residence

The Pollier Endowed Chair in Schizophrenia and Related Disorders

David Geffen School of Medicine at UCLA

Los Angeles, CA

Learning Objectives:

At the end of this CE activity, participants should be able to:

- Summarize the neurobiological substrates of depression and the mechanisms of action of alternate pharmacologic strategies.

- Evaluate remission rates for standard antidepressant therapies used in the management of depression.

- Analyze the efficacy and safety of atypical antipsychotics as adjunctive therapy for the treatment of major depressive disorder.

Target Audience:

Physicians, physician assistants, nurse practitioners, nurses, psychologists, social workers, certified case managers, pharmacists, and other healthcare professionals with an interest in mental health.

Commercial Support:

CME Outfitters, LLC, gratefully acknowledges an educational grant from Bristol-Myers Squibb Company and Otsuka America Pharmaceuticals, Inc., in support of this CE activity.

Credit Information:

CME Credit (Physicians):

CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CME Outfitters, LLC, designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Note to Physician Assistants: AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA Category I CME credit for the PRA from organizations accredited by ACCME.

CNE Credit (Nurses):

CME Outfitters, LLC, is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

It has been assigned code 6WASUP-PRV-0622. 1.0 contact hours will be awarded upon successful completion. This activity is co-provided with CME LLC.

Note to Nurse Practitioners: The content of this CNE activity pertains to Pharmacology.

CEP Credit (Psychologists):

CME Outfitters is approved by the American Psychological Association to sponsor continuing education for psychologists. CME Outfitters maintains responsibility for this program and its content. (1.0 CE credits)

NASW Credit (Social Workers):

This program was approved by the National Association of Social Workers (provider #886407722) for 1 continuing education contact hour.

CCMC Credit (Certified Case Managers):

This program has been approved for 1 hour by the Commission for Case Manager Certification (CCMC).

CPE Credit (Pharmacists):

CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)

Universal Program Number: 376-999-07-022-L01-P (live presentation) 376-999-07-022-H01-P (recorded programs)

Post-tests, credit request forms, and activity evaluations can be completed online at www.neuroscienceCME.com (click on the Testing/Certification link under the Resources tab - requires free account activation), and participants can print their certificate or statement of credit immediately (70% pass rate required). Otherwise, participants should fully complete and return both the credit request form and activity evaluation located within the course guide for this activity. A certificate or statement of credit will be mailed within 4-6 weeks to all who successfully complete these requirements.

About CME Outfitters:

CME Outfitters develops and distributes live, recorded, print, and web-based educational activities to thousands of clinicians each year and offers expert accreditation services for non-accredited organizations. For a complete catalog of certified activities, please visit http://www.cmeoutfitters.com, http://www.neuroscienceCME.com, or call 877.CME.PROS (877.263.7767).

About neuroscienceCME:

neuroscienceCME.com is the award-winning web portal serving clinicians, educators, and researchers in the neurosciences. Launched in October 2006, neuroscienceCME.com was custom designed to fill an identified gap in online resources for professionals around the world who are practicing in areas related to psychiatry, sleep disorders, addiction and substance abuse, ADHD, and other areas related to brain function. The site's primary mission is to be the professional's central forum for accessing, debating, synthesizing, and implementing the latest findings and best practices in the neurosciences.

About neuroscienceCME TV:

Offered as a simultaneous satellite broadcast, webcast, and telephone audioconference, neuroscienceCME TV is a one-hour, live and interactive continuing education (CE) activity where leading experts discuss clinically relevant, evidence-based issues facing mental health practitioners. Each broadcast's interactivity is enhanced by offering a Q&A segment during which the faculty presenters can respond to audience comments and questions posed via e-mail, fax, or phone. CME Outfitters has also developed a web-based instant polling feature that allows live webcast participants a chance to provide real-time input. Online CE credit is offered to participants upon completion of each activity, at neuroscienceCME.com.

To view all recent neuroscienceCME press releases, visit http://www.neuroscienceCME.com and click on "News Room" or visit http://www.prweb.com and search for "neuroscienceCME."

Clinical Compass, a bi-weekly e-newsletter published by CME Outfitters, is a convenient way to stay informed of all neuroscienceCME news and information. To subscribe, visit http://www.neuroscienceCME.com and click on "Subscribe to Clinical Compass."

Contact: Jessica Primanzon

CME Outfitters, LLC

240.243.1308 direct

240.243.1033 fax

###